04/23/2024 5:03 AM | Akoya Biosciences (Filer)
| Form DEF 14A | |
04/23/2024 5:04 AM | Akoya Biosciences (Filer)
| Form DEFA14A | |
04/23/2024 5:05 AM | Akoya Biosciences (Filer)
| Form ARS | |
03/25/2024 4:14 PM | Akoya Biosciences (Issuer) Ramachandran Niro Ph.D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 4:16 PM | Akoya Biosciences (Issuer) Pla Frederic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/25/2024 4:12 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 4:51 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4/A | |
|
03/22/2024 4:54 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/20/2024 4:56 PM | Akoya Biosciences (Subject) McKelligon Brian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/14/2024 7:40 PM | Akoya Biosciences (Issuer) SHEPLER ROBERT G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/14/2024 7:41 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:15 PM | Akoya Biosciences (Subject) McKelligon Brian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024 5:01 AM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4/A | |
03/01/2024 8:58 PM | Akoya Biosciences (Issuer) Ek John Frederick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 8:52 PM | Akoya Biosciences (Issuer) Ramachandran Niro Ph.D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 8:52 PM | Akoya Biosciences (Issuer) Pla Frederic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 8:53 PM | Akoya Biosciences (Issuer) Kamocsay Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/01/2024 8:21 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 8:11 AM | Akoya Biosciences (Subject) PSC Capital Partners LLC (Filed by)
| Form SC 13G/A | |
01/08/2024 5:02 AM | Akoya Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/03/2024 7:50 AM | Akoya Biosciences (Subject) Schindel Yair Chaim (Filed by)
| Form SC 13G/A | |
12/20/2023 6:16 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:24 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/12/2023 5:33 PM | Akoya Biosciences (Subject) McKelligon Brian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/27/2023 4:40 PM | Akoya Biosciences (Issuer) Kamocsay Jennifer (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/27/2023 4:41 PM | Akoya Biosciences (Issuer) Pla Frederic (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/20/2023 3:37 PM | Akoya Biosciences (Subject) McKelligon Brian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/13/2023 4:10 PM | Akoya Biosciences (Subject) Moy Marilee (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2023 5:28 PM | Akoya Biosciences (Subject) Moy Marilee (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2023 4:18 PM | Akoya Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/15/2023 2:31 PM | Akoya Biosciences (Subject) DRISCOLL JOSEPH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2023 5:16 PM | Akoya Biosciences (Subject) DRISCOLL JOSEPH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023 3:46 PM | Akoya Biosciences (Subject) DRISCOLL JOSEPH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2023 6:18 AM | Akoya Biosciences (Subject) Schindel Yair Chaim (Filed by)
| Form SC 13G | |
06/12/2023 5:18 PM | Akoya Biosciences (Issuer) Ek John Frederick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:15 PM | Akoya Biosciences (Issuer) Raffin Thomas A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:16 PM | Akoya Biosciences (Issuer) SHEPLER ROBERT G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:16 PM | Akoya Biosciences (Issuer) Winkler Matthew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:17 PM | Akoya Biosciences (Issuer) Mendel Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/12/2023 5:18 PM | Akoya Biosciences (Issuer) LAI GOLDMAN MYLA (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2023 3:32 PM | Akoya Biosciences (Filer)
| Form 424B5 | |
Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (Ad) Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs).
If these plans are implemented, it could mean the end of America as we know it. This means you must act NOW before it's too late. |
06/07/2023 3:40 PM | Akoya Biosciences (Filer)
| Form 424B5 | |
06/06/2023 8:45 PM | Akoya Biosciences (Issuer) McKelligon Brian (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2023 4:53 PM | Akoya Biosciences (Subject) DRISCOLL JOSEPH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2023 3:33 PM | Akoya Biosciences (Subject) McKelligon Brian (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023 4:54 PM | Akoya Biosciences (Issuer) Winkler Matthew (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 4:36 PM | Akoya Biosciences (Issuer) Nolan Garry Ph.D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 4:37 PM | Akoya Biosciences (Issuer) SCHNETTLER THOMAS P (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 4:37 PM | Akoya Biosciences (Issuer) SHEPLER ROBERT G (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 4:38 PM | Akoya Biosciences (Issuer) Mendel Scott (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2023 4:38 PM | Akoya Biosciences (Issuer) Raffin Thomas A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/01/2023 4:13 PM | Akoya Biosciences (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/31/2023 4:49 PM | Akoya Biosciences (Subject) DRISCOLL JOSEPH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2023 3:47 PM | Akoya Biosciences (Subject) DRISCOLL JOSEPH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2023 5:19 PM | Akoya Biosciences (Subject) DRISCOLL JOSEPH (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |